- Telehealth Visits
- Insurance plan information
Brie Fowler, NP
Medical Oncology- Telehealth Visits
- Insurance plan information
Cancer Center Burlingame
Brie Fowler, NP
Medical OncologyCancer Center Burlingame
- Telehealth Visits
- Insurance plan information
On this page
About me
Brie Fowler is a nurse practitioner who cares for patients with breast cancer. She focuses on helping them maintain comfort, hope and a good quality of life during challenging times.
Fowler earned her master's degree in nursing at Gonzaga University. Outside of work, she enjoys skiing and other outdoor activities.
Education & training
Board certification
- Family Nurse Practitioner, American Academy of Nurse Practitioners
Degree
- MSN, Gonzaga University
My expertise
Specialties
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%225466%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225466%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.